MN Community Measurement and the Endocrine Society (ES) are pleased to announce the completion of measure specifications for a suite of new measures aimed at improving the health outcomes and reducing modifiable risks for patients with obesity. This measure development project included conducting a measure landscape and evaluation of measures used previously in the Obesity Care Model Collaborative[1].
The Specifications Engineering Group (SEG) and Technical Expert Panel (TEP) meetings concluded in October 2021 with the recommendation to proceed with obtaining public comment on four measures currently under consideration prior to the pilot testing phase.
MNCM and ES are seeking public comment on the following measures:
Obesity Prediabetes and Diabetes HbA1c Control
The percentage of patients 12 to 75 years of age with a diagnosis of type 2 diabetes or prediabetes and whose most recent BMI is ≥ 27/BMI Percentile ≥ 95 during the measurement period. HbA1c target for patients with a diagnosis of prediabetes is less than 6.5. HbA1c target for patients with a diagnosis of type 2 diabetes is less than 8.0. View detail: Obesity Prediabetes and Diabetes A1c Control Measure.
Obesity Weight Loss with Medication
The percentage of adult patients 18 years of age and older whose most recent BMI is ≥ 30 or BMI ≥ 27 and comorbidities* or Asian descent and initiate a weight loss medication during the denominator identification period who have a weight loss of greater than or equal to 10% within six months (-30/+ 60 days). View detail: Obesity Weight Loss with Medication Measure.
Obesity Diagnosis
The percentage of adult patients 18 years of age and older whose most recent BMI is ≥ 30 or ≥ 27 with comorbidities* or Asian descent and children ages 2 to 17 whose most recent BMI percentile ≥ 95 during the measurement period and have the diagnosis of obesity active on their problem list. View detail: Obesity Diagnosis Measure.
Obesity Blood Pressure Control
The percentage of adult patients 18 to 85 years of age whose most recent BMI is ≥ 30 or ≥ 27 with comorbidities* or Asian descent whose most recent blood pressure during the measurement period is less than 140 systolic and less than 90 diastolic. View detail: Obesity Blood Pressure Control Measure.
* comorbidities of prediabetes, metabolic syndrome, type 2 diabetes, dyslipidemia, hypertension, obstructive sleep apnea and nonalcoholic fatty liver disease.
Comments may be submitted at PublicComment@mncm.org no later than Friday, December 17, 2021.
[1] Castellucci, M. New Care Model Helps Primary-Care Practices Treat Obesity Modern HealthCare 2/11/2021 www.modernhealthcare.com/care-delivery/new-care-model-helps-primary-care-practices-treat-obesity |
